Redhill Biopharma
RDHL
#11160
Rank
NZ$4.56 M
Marketcap
NZ$0.51
Share price
-13.08%
Change (1 day)
-72.38%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): NZ-$1,163

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is NZ-$1,280. In 2017 the company made an earnings per share (EPS) of NZ-$4,570 a decrease over its 2016 EPS that were of NZ-$4,022.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$1,163
2017NZ-$4,57013.64%
2016NZ-$4,0229.12%
2015NZ-$3,68568.01%
2014NZ-$2,194-25.93%
2013NZ-$2,961

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.62-100.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$1.82-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.26-100.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$0.82-100.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
NZ$2.23-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel